Recherche dans la base bibliographique AFSGT

Il y a 247 documents disponibles avec le champ Langue = "Anglais" : (cliquez dans pour voir le rÉsumÉ)

  1. Clonazepam in Gilles de la Tourette 's syndrome (multiple tic disorder)
    Auteur: ABUZZAHAB FS, HOPPER H
    Source: European journal of clinical pharmacology 36, suppl A 325, abstract n° PP, 1989
  2. School problems in Tourette's syndrome
    Auteur: ABWENDER DA, COMO PG, KURLAN R, PARRY K, FETT KA ,PLUM S ,DEELEY C
    Source: Arch Neurol, 53:509-511, 1996
  3. The genetics of Tourette's syndrome
    Auteur: ALSOBROOK JP, PAULS DL
    Source: Neurol Clin North Am, 1997, 15, 2, 381-393
  4. Clinical pharmacy case reports : Tourette's syndrome - Treatment with clonidine, a central acting alpha - adrenergic agonist.
    Auteur: AHSANUDDIN K, HALL K, PROSEN H
    Source: University of Manitoba
  5. Compulsive personality and serotonergic drugs
    Auteur: ANSSEAU M, TROISFONTAINES B, PAPART P, VON FRANCKELL R
    Source: Psychiatric Unit centre hospitalier universitaire de Liège, domaine universitaire du Sart Tilman
  6. EEG and brain mapping in Gilles de la Tourette Syndrome
    Auteur: BERGER Y, NEUFELD MY, KORCZYN AD et al
    Source: Neurology, 1990, 40, suppl 1, 362
  7. Relaxation therapy in Tourette Syndrome : a pilot study
    Auteur: BERGIN A, WARANCH HR, BROWN J et al
    Source: Pediat Neurol, 1998, 18, 2, 136-142
  8. The course and prognosis of Tourette Syndrome
    Auteur: BRUUN RD, BUDMAN CL
    Source: Neurol Clin North Am, 1997, 15, 2, 291-298
  9. Diagnostic and statistical manual of mental disorders IV
    Auteur: BRUUN RD, COHEN DJ, LECKMAN JF
    Source: photocopie
  10. RispÉridone as a treatment for Tourette's syndrome
    Auteur: BRUUN RD, BUDMAN CL
    Source: Journal of clinical psychiatry, 57 (1) : 29-31,
  11. The natural history of Gilles de la Tourette syndrome
    Auteur: BRUUN RD, BUDMAN CL
    Source: In : Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. Ed by Kurlan R, New York : M Dekker, 1993, 27-42
  12. Guide to the diagnosis and treatment of Tourette Syndrome
    Auteur: BRUUN RD, COHEN DJ, LECKMAN JF
    Source: Ed by Tourette Syndrome Association, New York
  13. Opiate therapy and self-harming behavior in Tourette's syndrome
    Auteur: BRUUN R, KURLAN R
    Source: Mov Disord, 1991, 6, 2, 184-185
  14. New TS treatment
    Auteur: BUCKINGHAM D, GAFFNEY G
    Source: J Am Acad Child adolesc Psychiatry, 1993, 32, 1, 224
  15. The impact of the September 11, 2001 disaster on people with Tourette Syndrome and associated disorders
    Auteur: BUDMAN CL, FEIRMAN-ROCKMORE, BRUUN RD
    Source: Tourette syndrome association, Inc, Internet
  16. Tourette's syndrome in Monroe County School Children
    Auteur: CAINE ED, MC BRIDE MC, CHIVERTON P et al
    Source: Neurology, 1998, n°129, 32-42)
  17. Genomic imprinting in Tourette's syndrome
    Auteur: CARON C, BRASSARD A, MERETTE C
    Source: Neurology, 1997, 49, 63-638
  18. Competing responses for the traitment of Tourette syndrome and tics disorders
    Auteur: CARR JE
    Source: Behav Res Ther, 1995, 33, 4, 455-456
  19. A brief behavior therapy protocol for Tourette syndrome
    Auteur: CARR JE, BAILEY JS
    Source: J. Behav. Ther. Exp Psychiat, vol 27, n° 1, 33-40, 1996
  20. A prospective longitudinal study of Gilles de la Tourette's Syndrome
    Auteur: CARTER AS, PAULS DL,, LECKMAN JF et al
    Source: J Am Acad Child Adolesc Psychiatry, 1994, 33, 3, 377-385
  21. Tics through Tourette's syndrome
    Auteur: CARTER JH
    Source: J Neurosci Nurs, 1991, 23, 3, 145-147
  22. Controlled stimulant treatment of ADHD and comorbid Tourette's Syndrome : Effects of stimulant and dose.
    Auteur: CASTELLANOS FX, GIEDD JN, ELIA J, MARSH W, RITCHIE GF, HAMBURGER SD, RAPOPORT J
    Source: J.Am.Acad. Child. Adolesc. Psychiatry, 36:5, May 1997
  23. Sequential use of opioid antagonists and agonists in Tourette's syndrome
    Auteur: CHAPELL PB
    Source: Lancet, 1994, 343, 556
  24. The pharmacologic treatment of tic disorders
    Auteur: CHAPELL PB, LECKMAN JF, RIDDLE MA
    Source: Child Adolescent Psychiatr Clin North Am, 1995, 4, 1, 197-216
  25. Guanfacine treatment of comorbid Attention - Deficit Hyperactivity Disorder and Tourette's Syndrome : Preliminary clinical experience
    Auteur: CHAPELL PB, RIDDLE MA, SCAHILL L et al
    Source: J Am Acad Child Adolesc Psychiatry, 1995, 34, 9, 1140-1146
  26. Future therapies of Tourette syndrome
    Auteur: CHAPELL PB, SCAHILL LD, LECKMAN JF
    Source: Neurol Clin North Am, 1997, 15, 2, 429-450
  27. Controlled stimulant treatment of ADHD and comorbid Tourette's Syndrome : Effects of stimulant and dose.
    Auteur: CASTELLANOS FX., M.D., GIEDD JN, ELIA J., MARSH W., RITCHIE GF, HAMBURGER SD, RAPOPORT J.
    Source: J.Am.Acad. Child. Adolesc. Psychiatry, 36:5, May 1997
  28. Tourette 's disorder and related problems : a review and update
    Auteur: COFFEY BJ, MIGUEL EC, SAVAGE CR et al
    Source: Harvard Rev Psychiatry, 1994, 2, 3, 121-132
  29. Behavioral and emotional aspects of Tourette syndrome
    Auteur: COFFEY B, PARK KS
    Source: Neurol Clin North Am, 1997, 15, 2, 277-289
  30. Sensory phenomena associated with Gilles de la Tourette's syndrome
    Auteur: COHEN AJ, LECKMAN JF
    Source: J Clin Psychiatry, 1992, 53, 9, 319-323
  31. Neuropsychiatric disorders of childhood : Tourette's syndrome as a model
    Auteur: COHEN DJ, LECKMAN JF, PAULS D
    Source: Acta Paediatr Suppl 422:106-111, 1997
  32. Clonidine ameliorates Gilles de la Tourette syndrome
    Auteur: COHEN DJ, DELTOR J, YOUNG G, SHAYWITZ BA
    Source: Arch Gen Psychiatry, Vol 37, Dec 1980
  33. Clonidine in Tourette's syndrome
    Auteur: COHEN DJ, NATHANSON JA, YOUNG JG, SHAYWITZ BA
    Source: the Lancet, sept 15, 1979
  34. Pharmacotherapy of Tourette's syndrome and associated disorders
    Auteur: COHEN DJ, RIDDLE MA, LECKMAN JF
    Source: Psychiatr Clin North Am, 1992, 15, 1, 109-129
  35. Comorbid Behavioral disorders
    Auteur: COMINGS DE, COMINGS BG
    Source: Handbook of SGT and related tics and behavorial disorders, ed by Kurlan, 1993
  36. Ts, learning and speech problems Comorbid behavorial disorders; in Tourette syndrome and related disorders
    Auteur: COMINGS DE, COMINGS BG
    Source: J. AM. ACAD. Child Adolesc Psychiatry, 33:3, March/april 1994, Kurlan R, ed NY, Marcel Decker, pp 111-147
  37. An open - label trial of fluoxetine for obsessive - compulsive disorder in Gilles de la Tourette's syndrome
    Auteur: COMO PG, KURLAN R
    Source: Neurology, 1991, 41, 872-874
  38. Neuropshychological testing
    Auteur: COMO PG
    Source: Handbook of SGT and related tics and behavorial disorders, ed by Kuala, 1993
  39. Gilles de la Tourette syndrome
    Auteur: CONSKY E., LANG A.E.
    Source: Medicine North America 3rd Series, 6436-37, 6440, 6444-46, 1989
  40. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder
    Auteur: COTTRAUX J, MOLLARD E, BOUVARD M, MARKS I, SLUYS M, NURY AM, DOUGE R, CIALDELLA P
    Source: International Clinical Psychopharmacology, 1990,5,17-30
  41. Clinical predictors of psychopathology in children and adolescents with Tourette syndrome
    Auteur: DE GROOT CM, JANUS MD, BORNSTEIN RA
    Source: J Psychiatr res, 1995, 29, 1, 59-70
  42. CYP2D6 Polymorphism and Gilles de la Tourette syndrome in pediatrics
    Auteur: DE LA TORRE R, LADONA MG, DICENTA S, MUFIOZ -YUNTA JA, VALL O, MASSAGUER J
    Source: Ist congress of European Association for clinical pharmacology and therapeutics, Paris, France,Sept 27-30, 1995,therapy suppl., n°61
  43. Tics and rispÉridone
    Auteur: DIANTONIIS M, HENRY KM, PARTRIDGE PAH et al
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 7, 839-840
  44. Exacerbation of motor tic and induction of new tic by halopÉridol use.
    Auteur: DIAZ JM, SMITH KG, MACCARIO M
    Source: West J Med 1992, Feb; 156:198-199
  45. Treatment of Gilles de la Tourette syndrome with Clonazepam
    Auteur: DION Y
    Source: Canadian College of Neuropsychopharmacology, CCNP, May 19-22, p.w-17, 1987
  46. Treatment of Gilles de la Tourette syndrome with Clonazepam
    Auteur: DION Y, CHOUINARD G
    Source: Canadian psychiatric association, 38 th annual meeting, Halifax, September 28-30, abstract n°72, p 119, 1988
  47. Guide pratique des mÉdicaments. 18° Édition*DODICK D, ADLER CH Tourette's syndrome : current approaches to recognition and management
    Auteur: DOROSZ P
    Source: Postgrad Med, 1992, 5, 299-308
  48. Assessment of DSM-III6R Personality Disorders by self-report. Questionnaire : The role of informants and a screening test for co-morbid personnality (STCPD)
    Auteur: DOWSON JH
    Source: Bristish journal of psychiatry, 1992, 161, 344-352
  49. Therapeutical effects of clonidine and Clonazepam in children with tick syndrome
    Auteur: DRTILKOVA I, BALASTIKOVA B, LEMANOVA H
    Source: Homeostasis, 1994, 35, 6, 296
  50. Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome
    Auteur: DURSUN SM, BIRD R, REVELEY MA
    Source: Br J Clin Pharmacol, 1995, 39, 1, 100P-101P
  51. Longlasting improvement of Tourette's syndrome with transdermal nicotine
    Auteur: DURSUN SM, REVELEY MA, BIRD R et al
    Source: Lancet, 1994, 344, 1577
  52. Buspirone treatment of Tourette's syndrome
    Auteur: DURSUN SM, BURKE JG, REVELEY MA
    Source: The Lancet, Vol 345, may 27, 1995
  53. The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome
    Auteur: DURSUN SM, REVELEY MA
    Source: Eur Psychiatry, 1996, 11, 4, 204-206
  54. Longlasting improvement of Tourette's syndrome with transdermal nicotine
    Auteur: DURSUN SM, REVELEY MA, BIRD R et al*
    Source: Lancet, 1994, 344, 1577
  55. Dose - escalated application of transdermal nicotine in Tourette's syndrome
    Auteur: DURSUN SM, REVELEY MA, STIRTON RF
    Source: J psychopharmacol, 1995, 9, 3, suppl, 98
  56. All that tics may not be Tourette's
    Auteur: EAPEN V, ROBERTSON MM
    Source: Department of psychiatry, university college London Medical School, London WIN 8AA
  57. Evidence for autosomal dominant transmission in Tourette's syndrome : United Kingdom cohort study
    Auteur: EAPEN V, PAULS DL, ROBERTSON MM
    Source: Br J Psychiatry, 1993, 162, 593-596
  58. Gilles de la Tourette's syndrome in special education schools : a United Kingdom study
    Auteur: EAPEN V, ROBERTSON MM, ZEITLIN H et al
    Source: J Neurol, 1997, 244, 378-382
  59. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours : preliminary clinical experience
    Auteur: EAPEN V, TRIMBLE MR, ROBERTSON MM
    Source: Prog NeuroPsychopharmacol Biol Psychiatry, 1996, 20,737-743
  60. The metabolic anatomy of Tourette's syndrome
    Auteur: EIDELBERG D, MOELLER JR, ANTONINI A, KAZUMATA K, DHAWAN V, BUDMAN C, FEIGIN A
    Source: neurology, vol 48 n°4, 927-934, 1997
  61. Gilles de la Tourette's syndrome : effets of stimulant drugs
    Auteur: ERENBERG G, CRUSE RP, ROTHNER AD
    Source: Neurology, 1985, 35, 1346-1348
  62. Neurobiological findings in children with tics and Gilles de la Tourette
    Auteur: EGGERS C, OLBRICHT T, ROTHENBERGER A
    Source: In proceeding of the symposium on special aspects of psychopharmacology, Sainte-Maxime (France) 1982, avril 25-30; p 191-202
  63. Naltrexone in the treatment of Tourette's syndrome
    Auteur: ERENBERG G, LEDERMAN RJ
    Source: neurology, 39, suppl 1, 232, 1989
  64. Motor and vocal tics In : Handbook of Tourette's syndrome and Related tic and behavioral disorders ed by Kurlan R
    Auteur: FAHN S
    Source: New York : M Dekker, 1993, 3-15
  65. A controlled trial of Deprenyl in children with Tourette's syndrome and deficit hyperactivity disorder
    Auteur: FEIGIN A, KURLAN R, Mc DERMOTT MP et al
    Source: Neurology, 1996, 46, 965-968
  66. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder
    Auteur: FENNIG S, FENNIG SN, PATO M, WEITZMAN A
    Source: British journal of psychiatry, 164 (6) : 839-841, juin 1994
  67. Obsessions and compulsions in Gilles de la Tourette's syndrome
    Auteur: FRANKEL M, CUMMINGS J, ROBERTSON MM, TRIMBLE MR, HILL MA, BENSON F
    Source: Neurology 36, March 1986, 378-382
  68. Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome
    Auteur: FRANKENBURG FR, KANDO JC
    Source: J Clin Psychopharmacol, 1994, 14, 5, 359-360
  69. Guanfacine for Tourette's disorder
    Auteur: FRAS I
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 1, 3-4
  70. Fluvoxamine versus Clomipramine in the treatment of obsessive compulsive disorder : a multicenter, randomized, double-blind, parallel group comparison
    Auteur: FREEMAN CPL, TRIMBLE MR, DEAKIN JFW, STOKES TM, ASHFORD JJ
    Source: J Clin Psychiatry 555:7, july 1994
  71. Attention Deficit Hyperactivity Disorder in the presence of Tourette syndrome
    Auteur: FREEMAN RD
    Source: Neurol Clin North Am, 1997, 15,2, 411-420
  72. Fluoxetine in Tourette's syndrome
    Auteur: GATTO E, PIKIELNY R, MICHELI F
    Source: Am J Psychiatry, 1994, 151, 6, 946-947
  73. rispÉridone treatment for Tourette's disorder patient with comorbid obsessive-compulsive disorder
    Auteur: GIAKAS WJ
    Source: Am J Psychiatry, 1995, 152, 7, 1097-1098
  74. Clonidine In Handbook of Tourette's syndrome and releated tic and behavorial disorders ed by Kurlan R
    Auteur: GOETZ CG
    Source: New York : M Dekker, 1993, 377-387
  75. Clonidine et clonazepam in Tourette syndrome in : Advances in Neurology, vol 58 ed by Chase TN, Friedhoff AJ, Cohen DJ
    Auteur: GOETZ CG
    Source: New York : Raven Press, 1992, 245-251
  76. Talipexole and adult Gilles de la Tourette's syndrome : double-blind, placebo-controlled clinical trial
    Auteur: GOETZ CG, STEBBINS GT, THELEN JA
    Source: Movement disorders, Vol 9, n°3, 315-317, 1994
  77. Adult tics in Gilles de la Tourette's syndrome : Description and risk factors.
    Auteur: GOETZ CG, TANNER CM, STEBBINS GT et al
    Source: Neurology, 1992, 42, 784-788
  78. Treatment of attention deficit hyperactivity disorder In Handbook of Tourette's syndrome and related tic and behavorial disorders ed by Kurlan R
    Auteur: GOLDEN GS
    Source: New York : M Dekker, 1993, 423-430
  79. Coprolalia in younger patients with Gilles de la Tourette syndrome
    Auteur: GOLDENBERG JN, BROWN SB, WEINER WJ
    Source: Mov Disord, 1994, 9, 6, 622-625
  80. Tic disorders in childhood
    Auteur: GOLDEN GS
    Source: pediatrics in review, vol 8 n°8, fevrier 1987
  81. Biological approaches to treatment resistant obsessive compulsive disorder
    Auteur: GOODMAN WK, DOUGLE CJ, BARR LC, ARONSON SC, PRICE LH
    Source: J Clin Psychiatr 54:6 (suppl), juin 1993
  82. Seven cases of Gilles de la Tourette's Syndrome : partial relief with clonazepam : a pilot study
    Auteur: GONCE M, BARBEAU A
    Source: Canadian journal of neurological sciences, Vol4, n°4, 279-283
  83. Bupropion for SSRI - induced fatigue
    Auteur: GREEN T
    Source: J Clin Psychiatry 58 :4, avril 1997
  84. La rispÉridone amÉliore-t-elle la mÉmoire verbale immÉdiate chez les schizophrènes rÉsistants au traitement ?
    Auteur: GREEN MF, MARSHALL BD, WIRSHING WC, AMES D, MARDER SR, Mc GURK S, KERN RS, MINTZ J
    Source: The American Journal of Psychiatry, 154 (6), 799-804, 1997
  85. Pergolide in the management of Tourette syndrome
    Auteur: GRIESEMER DA
    Source: Journal of Child neurology, Vol 12, N° 6, 402-403, Sept 1997
  86. Basal ganglia - limbic system interactions
    Auteur: HABER SN, LYND-BALTA E
    Source: Handbook of TS and related tics and behavorial disorders, R Kurla, ed M Dekker, 243-289, 1993
  87. Combined pharmacotherapy for TS and OCD
    Auteur: HAWKRIDGE S, STEIN DJ, BOUWER C
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 6, 703-704
  88. SGT [ I-123 ]Bêta-CIT SPECT correlates of vocal tic severity
    Auteur: HEINZ A, KNABLE MB, WOLF SS, JONES DW, GOREY JG, HYDE TM, WEINBERGER DR
    Source: Neurology, 51:1069-1074, 1998
  89. The use of benzodiazepines in obsessive compulsive disorder and Tourette's syndrome
    Auteur: HEWLETT WA
    Source: Psychiatr Ann, 1993, 23, 6, 309-316
  90. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with Desipramine
    Auteur: HOGE SK, BIEDERMAN J
    Source: J Clin psychiatry, 1986, 47, 9, 478-479
  91. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins
    Auteur: HYDE TM, AARONSON BA, RANDOLPH C et al
    Source: Neurology, 1992, 42, 652-658
  92. Clomipramine efficacy for Tourette syndrome and major depression : a case study
    Auteur: IANCU I, KOLTER M, BLEICH A et al
    Source: Biol Psychiatry, 1995, 38, 6, 407-409
  93. Obsessionality in Tourette syndrome
    Auteur: JADRESIC D
    Source: Lancet, 1993, 341, 8852, 1063
  94. Clozapine in tardive Tourette Syndrome
    Auteur: JAFFE E, TREMEAU F, SHARIF Z et al
    Source: Biol Psychiatry, 1995, 38, 3, 196-197
  95. Motor, behavioral and pharmacologic findings in Tourette's syndrome
    Auteur: JANKOVIC J, ROHAIDY H
    Source: Canada journal of Neurological sciences 14, 541-546, 1987
  96. Botulinum toxin in the treatment of tics In Therapy with botulinum Toxin ed by Jankovic J and Hallet M
    Auteur: JANKOVIC J
    Source: New York : M Dekker, 1994, 503-509
  97. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette 's syndrome
    Auteur: JANKOVIC J, GLAZE DG, FROST JD
    Source: Neurology 34, n°5, 688-92, 1984
  98. Phenomenology and classification of tics
    Auteur: JANKOVIC J
    Source: Neurol Clin North Am, 1997, 15, 2, 267-275
  99. Botulinum toxin in movement disorders
    Auteur: JANKOVIC J
    Source: Current Opin Neurol, 1994, 7, 358-366
  100. Botulinum toxin in the treatment of distonic tics
    Auteur: JANKOVIC J
    Source: Mov Disord, 1994, 9, 3, 347-349
  101. Deprenyl in attention deficit associated with Tourette's syndrome
    Auteur: JANKOVIC J
    Source: Arch neurol, 1993, 50, 3, 286-288
  102. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette 's syndrome
    Auteur: JANKOVIC J, GLAZE DG, FROST JD
    Source: Neurology 34, n°5, 688-92, 1984
  103. tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias
    Auteur: JANKOVIC J, ORMAN J
    Source: Neurology, 1988, 38, 391-394
  104. Dermatological manifestations of Tourette syndrome and obsessive compulsive disorder
    Auteur: JANKOVIC J, SEKULA S, MILAS D et al
    Source: Arch Dermatol, 1998, 134, 1; 113-114
  105. Cholinergic strategies in Tourette Syndrome : an open label trial of tarine hydrochloride
    Auteur: JUNCOS, VICKI, ROBERTS, ATLANTA GA, TRACY, WALDECK, ATHENS, GA
    Source: Neurology 48, March 1997(S69.003), vol 48 n°3, Suppl 2
  106. A case of Gilles de la Tourette's syndrome treated with clonazepam
    Auteur: KAIM B
    Source: brain research bulletin, Vol 11, N° 2, 213-214, 1983
  107. Clinical characteristics of Tourette syndrome
    Auteur: KANO Y, OHTA M, NAGALI Y
    Source: Psychiatr Clin Neurosci, 1998, 52, 1, 51-57
  108. Extracorporel "phantom" tics in Tourette's syndrome
    Auteur: KARP BI, HALLETT M
    Source: Neurology, 1996, 46, 38-40
  109. Clonidine in Tourette syndrome
    Auteur: KEITH IG, WILLIAMS A, NICOL AR
    Source: The Lancet, january 31, 1981
  110. Antineural antibodies in movement disorders
    Auteur: KIESSLING LS, MARCOTTE AC, CULPEPPER L
    Source: Pediatrics, 1993, 92, 1, 39-43
  111. The treatment of obsessive compulsive disorder in Tourette's syndrome. In : Handbook of Tourette's Syndrome and related tics and behavioral disorders ed by Kurlan R
    Auteur: KING RA, VITULANO LA, RIDDLE MA
    Source: New York : M Dekker, 1993, 401-421
  112. Clinical rating and quantitative assessment of tics
    Auteur: KOMPOLITI K, GOETZ CG
    Source: Neurol Clin North Am, 1997, 15, 2, 239-254
  113. Future therapies In : Handbook of Tourette's syndrome and related tics and behavioral disorders ed by Kurla R
    Auteur: KORCZYN AD
    Source: New York : M DEKKER, 1993, 481-490
  114. Facial tics
    Auteur: KOWAL L
    Source: Aust Fam Physician, 1994, 24, 10, 1870-1871
  115. Severe motor tics causing cervical myelopathy in Tourette's syndrome
    Auteur: KRAUSS JK, JANKOVIC J
    Source: Mov Disord, 1996, 11, 5, 563-566
  116. Secondary tic disorders
    Auteur: KUMAR R, LANG AE
    Source: Neurol Clin North Am, 1997, 15, 2, 309-331
  117. Treatment of tics
    Auteur: KURLAN R
    Source: Neurol Clin North Am, 1997, 15, 2, 403-409
  118. Future direction of research in Tourette syndrome
    Auteur: KURLAN R
    Source: Neurol Clin North Am, 1997, 15, 2, 451-456
  119. Tourette's syndrome : current concepts
    Auteur: KURLAN R
    Source: Neurology, 1989, Dec, 39, 1625-1630
  120. A pilot controlled study of fluoxetine for obsessive compulsive symptoms in children with Tourette's syndrome
    Auteur: KURLAN R, COMO PG, DEELEY C et al
    Source: Clin Neuropharmacol, 1993, 16, 2, 167-172
  121. Non-obscene complex socially inappropriate behavior in Tourette's syndrome
    Auteur: KURLAN R, DARAGJATI C, COMO PG et al
    Source: J Neuropsychiatry Clin Neurosci, 1996, 8, 3, 311-317
  122. Bilineal transmission in Tourette's syndrome families
    Auteur: KURLAN R, EAPEN V, STERN J et al
    Source: Neurology, 1994, 44, 2336-2342
  123. Sensory tics in Tourette's Syndrome
    Auteur: KURLAN R, LICHTER D, HEWITT D
    Source: Neurology, 1989, 39, 731-734
  124. Rating tic severity in : Handbook of Tourette's syndrome and related behavioral disorders ed by Kurlan R
    Auteur: KURLAN R, MC DERMOTT MP
    Source: New York : M DEKKER, 1993, 199-220
  125. Treatment of tics In Treatment of movement disorders ed by KURLAN R
    Auteur: KURLAN R, TRINITAD KS
    Source: Philadelphia : JB Lippincott, 1995, 365-406
  126. Pergolide : a review of its pharmacological properties and therapeutic potential in Parkinson's desease.
    Auteur: LANGTRY HD, CLISSOLD SP
    Source: Drugs 39(3):491-506;ADIS Drug Information Services,Auckland,New Zeland
  127. Premonitory ("sensory") experiences in : Handbook of Tourette's Syndrome and related tic and behavorial disorders ed by Kurlan R
    Auteur: LANG AE
    Source: New York : M Dekker, 1993, 17-25
  128. Patient perception of tics and other movement disorders
    Auteur: LANG AE
    Source: Neurology, 1991, 41, 223-228
  129. On the use of clonidine and thioproperazine in a woman with Gilles de la Tourette 's Disease
    Auteur: LECHIN F, VAN DER DIJS B, GOMEZ F, ACOSTA E, AROCHA L
    Source: Biological psychiatry, Vol 17, N°1, 1982.
  130. Growth hormone response to clonidine in children ages 4-17 : Tourette's syndrome vs. children with short stature
    Auteur: LECKMAN JF, COHEN DJ, GERTNER JM, ORT S, HARCHERIK DF
    Source: Journal of the american academy of child psychiatry, 23, 2:174-181
  131. Gilles de la Tourette's syndrome and some forms of obsessive compulsive disorder may share a common genetic diathesis
    Auteur: LECKMAN JF, CHITTENDEN EH
    Source: L'EncÉphale, 1990, 16, 321-323
  132. Clonidine treatment of Gilles de la Tourette's syndrome
    Auteur: LECKMAN JF, HARDIN MT, RIDDLE MA et al
    Source: Arch Gen Psychiatry, 1991, 48, 324-328
  133. Course of tic severity in Tourette syndrome : The first two decades.
    Auteur: LECKMAN JF, ZHANG H, VITALE A, LAHNIN F , LYNCH K, BONDI C, KIM YS, PETERSON BS
    Source: Pediatrics, Vol 102, n° 1, july 1998
  134. Self-touching tics in Tourette's syndrome induced by comorbid somatic and cognitive psychiatric symptoms
    Auteur: LEON M, BERTHIER M, KULISEVSKY J
    Source: Neurology 50, april 1998, P01.112
  135. Pharmacotherapy beyond the catecholaminergic system
    Auteur: LEWITT PA
    Source: Handbook of Tourette's syndrome related tic and behavorial disorders Ed by R Kurlan, 1993
  136. 156 cases of Gilles de la Tourette's syndrome treated by acupuncture
    Auteur: LIANZHONG W, HUIMIN L, LING K
    Source: J Tradit Chin Med, 1996, 16, 3, 211-213
  137. Parkinson's disease : Tourette's syndrome (P02.111). Predictors of neuroleptic requirement following clonidine trial in Tourette syndrome.
    Auteur: LICHTER DG, TRINITAD KS, JACKSON LA
    Source: Neurology 46.2, Suppl, 200-: Abstract. P02.111,1996
  138. Predictors of clonidine response in Tourette syndrome : implications and interfÉrences
    Auteur: LICHTER DG, JACKSON LA
    Source: J Child Neurol, 1996, 11, 93-97
  139. Clinical evidence of genomic imprinting in Tourette's syndrome
    Auteur: LICHTER DG, JACKSON LA, SCHACHTER M
    Source: Neurology, 1995, 45, 924-928
  140. Influence of family history on clinical expression of Tourette Syndrome
    Auteur: LICHTER DH, TRINIDAD KS, JACKSON LA
    Source: Neurology 48, S69.005, march 1997
  141. Dopamine agonist treatment of Tourette disorder in children : results of an open-label trial of pergolide
    Auteur: LIPINSKI JF, SALLEE FR, JACKSON C, SETHURAMAN G
    Source: Mov disord, vol 12 (3), 402-407, ISSN:0885-3185, 1997
  142. rispÉridone
    Auteur: LIVINGSTON MG
    Source: Lancet, 1994, 343, 457-460
  143. rispÉridone treatment of children and adolescents with chronic tic disorders : a preliminary report
    Auteur: LOMBROSO PJ, SCAHILL L, KING RA et al
    Source: J Am Acad Child Adolesc Psychiatry, 1995, 34, 9, 1147-1152
  144. Stimulant medications precipitate Tourette's syndrome
    Auteur: LOWE TL, COHEN DJ, DELTOR J et al
    Source: JAMA, 1982, 247, 12, 1729-1731
  145. Fluoxetine use in Tourette syndrome
    Auteur: LUM L
    Source: Can J Hosp Pharm, 1991, 44, 6, 301
  146. Sequential use of opioid antagonists and agonists in Tourette's syndrome
    Auteur: Mc CONVILLE BJ, NORMAN AB, FOGELSON MH et al
    Source: Lancet, 1994, 343, 601
  147. The prevalence of Tourette's syndrome in a mainstream school population
    Auteur: MASON A, BANERJEE S, EAPEN V, ROBERTSON MM
    Source: Developmental medicine & Child neurology, 40, 292-296, 1998
  148. Blood choline and response to clonazepam and halopÉridol in Tourette's syndrome
    Auteur: MENKANGAS JR, MENKANGS KR, KOPP U, HANIN I
    Source: Acta psychiatra. scand. 72, n°4, 395-399, 1985
  149. halopÉridol therapy in Tourette's syndrome : neurophysiological, biochimical and behavioral correlates
    Auteur: MESSINA FS, KNOPP W, VANECKO S, O'BRIEN V, CORSON A
    Source: Life sciences, Vol 10, Part I, 449-457, 1971
  150. Methadone treatment of Tourette's disorder
    Auteur: MEULDIJK R, COLON EJ
    Source: Am J Psychiatry, 1992, 149, 1, 139-140
  151. Phenomenological differences appearing with repetitive behaviours in obsessive compulsive disorder and Gilles de la Tourette's syndrome
    Auteur: MIGUEL EC, BAER L, COFFEY BJ et al
    Source: Br J Psychiatry, 1997, 170, 140-145
  152. Tolerance of tetrabenazine during long-term treatment
    Auteur: MIKKELSEN BO
    Source: Acta neurol scand, 68:57-60, 1983
  153. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette's syndrome and other motor disorders
    Auteur: MOSS DE, MANDERSCHEID PZ, MONTGOMERY SP, NORMAN AB, SANBERG PR
    Source: Life sciences, Vol 44, pp, 1521-1525, pergamon press
  154. Tardive Tourette's syndrome treated with clonidine and mesoridazine
    Auteur: MUNETZ MR, SLAWSKY RC, NEIL JF
    Source: Psychosomatics, March 1985, Vol 26, N°3
  155. Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential
    Auteur: OBESO JA, ROTHWELL JC, MARSEN CD et al
    Source: J Neuro Neurosurg Psychiatry, 1981, 44, 735-738
  156. Social and educational resources for patients with Tourette syndrome
    Auteur: PACKER LE
    Source: Neurol Clin North Am, 1997, 15, 2, 457-471
  157. Disappearance of motor tics after Wernicke's encephalopathy in a patient with Tourette's syndrome
    Auteur: PANTONI L, LOREDANA P, REPICE A, INZITARI D
    Source: Neurology, Vol 48, n°2, Feb 1997
  158. The early course of the Tourette's syndrome clinical spectrum
    Auteur: PARK S, COMO PG, CUI L et al
    Source: Neurology, 1993, 43, 1712-1715
  159. Clinical differences between subjects with familial and nonfamilial Tourette's syndrome
    Auteur: PARRAGA H, SPINNER L
    Source: Can J Psychiatry, 1996, 41, 9, 606
  160. Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorders
    Auteur: PAULS DL, LECKMAN JF, COHEN DJ
    Source: Br J Psychiatry, 1994, 164, 2, 125-221
  161. Pediatric psychopharmacology : Tourette's syndrome
    Auteur: PERRY PJ, ALEXANDER B, ELLINGROD VL
    Source: The virtual Hospital : Clinical Psychophamacology Seminar 1996-1997 , Peer Review Status : none http://www.vh.org/Providers/Conferences/CPS/42.html
  162. Steroid hormones and Tourette's syndrome : early experience with antiandrogen therapy
    Auteur: PETERSON BS, LECKMAN JF, SCAHILL L, NAFTOLIN F, KEEFE D, CHAREST NJ, KING RA, HARDIN MT, COHEN DJ
    Source: Journal of clinical psychopharmacology, vol 14, n° 2, 131-135,
  163. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome
    Auteur: PETERSON BS
    Source: J Clin Psychiatry, 1996, 57, suppl 9, 24-34
  164. The treatment of Tourette's syndrome : multimodal, developmental intervention
    Auteur: PETERSON BS, COHEN DJ
    Source: J Clin Psychiatry, 1996, 59, suppl 1, 62-74
  165. Reduced basal ganglia volumes in Tourette's syndrome using three dimensional reconstruction techniques from magnetic resonance images
    Auteur: PETERSON BS, RIDDLE MA, COHEN DJ et al
    Source: Neurology, 1993, 43, 941-949
  166. Medical and surgical treatment of obsessive compulsive disorder
    Auteur: RAPOPORT JL, INOFF-GERMAIN G
    Source: Neurol Clin North Am, 1997, 15, 2, 421-428
  167. Tourette's syndrome in monozygotic twins; Relationship of tic severity to neuropsychological function
    Auteur: RANDOLPH C, HYDE TM, GOLD JM, GOLDBERG TE, WEINBERGER DR
    Source: Arch neurol, Vol 50, 725-728, 1993
  168. A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome
    Auteur: RASMUSSON AM, ANDERSON GM, LYNCH KA, Mc SWIGGAN-HARDIN M, SCAHILL LD, MAZURE CM, GOODMAN WK, PRICE LH, COHEN DJ, LECKMAN JF
    Source: Biol Psychiatry, 41:117-121, 1997
  169. Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive compulsive disorder : a case study
    Auteur: RATZONI G, HERMESH H, BRANDT N et al
    Source: Biol Psychiatry, 1990, 27, 95-98
  170. Combined pharmacotherapy of Gilles de la Tourette's syndrome
    Auteur: REGEUR I, PAKKENBERG B, PAKKENBERG H, FOQ R
    Source: Acta Neurologica scandinavica 65, Suppl.90, 308-309, 1982
  171. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy
    Auteur: RICKARDS H
    Source: seizure, 1995, 4, 259-266
  172. Vomiting and retching in Gilles de la Tourette syndrome : un rapport de dix cas et une revue de la littÉrature
    Auteur: RICKARDS H, ROBERTSON M
    Source: Movement disorders, Vol n° 12, N°4, 531-535, 1997
  173. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders preliminary clinical experience
    Auteur: RIDDLE MA, HARDIN MT, KING R et al
    Source: J Am Acad Child Adolesc Psychiatry, 1990, 29, 1, 45-48
  174. Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome
    Auteur: RIDDLE MA, LECKMAN JF, HARDIN MT ANDERSON GM, COHEN DJ
    Source: Am J Psychiatry, 145 : 9, sept. 1988
  175. Personnality disorder and psychopathology in Tourette's syndrome : a controlled study
    Auteur: ROBERTSON MM, BANERJEE S, HILEY PJF et al
    Source: Br J Psychiatry, 1997, 171, 283-286
  176. Tourette's syndrome in the year 2000
    Auteur: ROBERTSON MM, BOARDMAN J
    Source: Austr N Z J Psychiatry, 1996, 30, 749-759
  177. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette' s syndrome
    Auteur: ROBERTSON MM, EAPEN V
    Source: Clin Neuropharmacol, 1992, 15, 5, 408-425
  178. Suicide in Gilles de la Tourette's syndrome : report of 2 cases
    Auteur: ROBERTSON MM, EAPEN V, VAN DE WETERING BJM
    Source: J Clin Psychiatry, 1995, 56, 8, 378
  179. rispÉridone in the treatment of Tourette's syndrome : a retrospective case note study
    Auteur: ROBERTSON MM, SCULL DA, EAPEN V et al
    Source: J Psychopharmacol, 1996, 10, 4, 317-320
  180. The Gilles de la Tourette syndrome
    Auteur: ROBERTSON MM, STERN JS
    Source: Rit Rev Neurobiol, 1997, 11, 1, 1-19
  181. rispÉridone in the treatment of Tourette syndrome : a retrospective case note study.
    Auteur: ROBERTSON MM, SCULL DA, EAPEN V, TRIMBLE MR
    Source: Journal of Psychopharmacology, 10 (4), 317-320, 1996
  182. Gilles de la Tourette syndrome
    Auteur: ROBERTSON MM, STERN JS
    Source: Br J Hosp Med, 1997, 58, 6, 253-256
  183. Tourette's syndrome in New Zealand, a postal survey
    Auteur: ROBERTSON MM, VERRILL M, MERCER M et al
    Source: Br J Psychiatry, 1994, 164, 263-266
  184. The increasingly complex genetics of Tourette's syndrome
    Auteur: SADOVNICK D, KURLAN R
    Source: Neurology, 1997, 48, 801-802
  185. Prolactin monitoring of halopÉridol and pimozide treatment in children with Tourette's syndrome
    Auteur: SALLEE FR, DOUGHERTY D, SETHURAMAN G, VRINDAVANAM N
    Source: Biol. Psychiatry, 1996, 40, 1044-1050
  186. Relative efficacy of halopÉridol and pimozide in children and adolescents with Tourette's disorder
    Auteur: SALLEE FR, NESBITT L, JACKSON C et al
    Source: Am J Psychiatry, 1997, 154, 1057-1062
  187. Botulism toxin for refractory vocal tics
    Auteur: SALLOWAY S, STEWART CF, ISRAELI L et al
    Source: Mov Disord, 1996, 11, 6, 746-748
  188. Nicotine gum and halopÉridol in Tourette's syndrome
    Auteur: SANBERG PR, FOGELSON HM, MANDERSCHEID PZ et al
    Source: Lancet, 1988, 592
  189. Clinical management of Tourette's syndrome and associated disorders
    Auteur: SANDOR P
    Source: Can J Psychiatry, 1995, 40, 10, 577-583
  190. Beneficial effects of imipramine on Tourette's syndrome
    Auteur: SANDYK R, BAMFORD CR
    Source: Intern J Neurosci, 1988, 39, 27-29
  191. Tourette's syndrome, part II : Contemporary approaches to assessment and treatment
    Auteur: SCAHILL L, ORT SI, HARDIN MT
    Source: Arch Psychiatr Nurs, 1993, 7, 4, 209-216
  192. Clozapine in Tourette's syndrome
    Auteur: SCHMIDER J
    Source: J Clin Psychopharmacol, 1998, 18, 1, 88-89
  193. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
    Auteur: SCOTT BL, JANKOVIC J, DONOVAN DT
    Source: Mov Disorders, 1996, 11, 4, 431-433
  194. Palicoprolalia : an unusual variant of palilalia in Gilles de la Tourette's syndrome
    Auteur: SERRA - MESTRES J, ROBERTSON MM, SHETTY T et al
    Source: J Neuropsychiatry Clin Neurosci, 1998, 10, 1, 117-118
  195. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome
    Auteur: SHAPIRO NA, Mc CONVILLE BJ, PAGNUCCO ML et al
    Source: J Clin Psychiatry, 1997, 58, 4, 174-175
  196. Neuroleptic drugs In Handbook of Tourette's syndrome and related tic and behavioral disorders ed by Kurlan R
    Auteur: SHAPIRO AK, SHAPIRO ES
    Source: New York : M Dekker, 1993, 347-375
  197. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics
    Auteur: SHAPIRO AK, SHAPIRO ES, EISENKRAFT GJ
    Source: arch Gen psychiatry; Vol 40, Nov 1983
  198. Gilles de la Tourette syndrome, 2° Édition
    Auteur: SHAPIRO AK, SHAPIRO ES, YOUNG TG
    Source: New York, Raven Press, 1988, 151, 356-361, 423-449, 481-501
  199. Treatment of tic disorders
    Auteur: SHAPIRO AK, SHAPIRO ES, YOUNG TG, FEINBERG TE,
    Source: Gilles de la Tourette, 2nde Édition, Raven Press NY, 1988, 423-449
  200. RispÉridone in Gilles de la Tourette's syndrome
    Auteur: SHULMAN LM, SINGER C, WEINER WJ
    Source: Neurology, 1995, 45, 1419
  201. Transdermal nicotine for Tourette's syndrome
    Auteur: SHYTLE RD, SILVER AA, PHILIPP MK et al
    Source: Drug Dev Res, 1996, 38, 290-298
  202. Persistent tardive dyskinesia and other neuroleptic related dyskinesia in Tourette's disorder
    Auteur: SILVA RR, MAGEE HJ, FRIEDHOFF AJ
    Source: J Child Adolesc Psychopharmacol, 1993, 3, 3, 137-144
  203. Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder
    Auteur: SILVA RR, MUNOZ DM, BARICKMAN J, FRIEDHOFF AJ
    Source: J Child Psychol Psychiat, Vol 36, N° 2, 305-312, 1995
  204. Causes of halopÉridol discontinuation in patients with Tourette's disorder : Management and alternatives.
    Auteur: SILVA RR, DINOHRA MD, DANIEL W, BARICKMAN J, FRIEDHOFF AJ
    Source: J Clin Psychiatry, 57 :3, Mars 1996
  205. Neuroleptic withdrawal psychosis in Tourette's disorder
    Auteur: SILVA RR, FRIEDHOFF AJ, ALPERT M
    Source: Biol.Psychiatry, 1993; 34; 341-342.
  206. Transdermal nicotine patch and potentiation of halopÉridol in Tourette's syndrome
    Auteur: SILVER AA, SANBERG PR
    Source: Lancet, 1993, 342, 182
  207. Case study : long term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome
    Auteur: SILVER AA, SHYTLE RD, PHILIPP MK et al
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 12, 1631-1636
  208. Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome
    Auteur: SILVESTRI R, RAFFAELE M, DE DOMINICO P, TISANO A, LAGANA A, DI PERRI R
    Source: Acta neurologica, 16 (1-2) : 58-63, feb-Apr 1994
  209. Coprolalia and other coprophenomena
    Auteur: SINGER C
    Source: Neurol Clin North Am, 1997, 15, 2, 299-308
  210. Pathologie
    Auteur: SINGER HS
    Source: Handbook of SGT and related tics and behavioral disorders, RKurlan, Ed Dekker, 1993
  211. Neurobiology of Tourette syndrome
    Auteur: SINGER HS
    Source: Neurol Clin North Am, 1997, 15, 2, 357-379
  212. The treatment of attention deficit hyperactivity disorder in Tourette's syndrome : a double blind placebo - controlled study with clonidine and desipramine
    Auteur: SINGER HS, BROWN J, QUASKEY S et al
    Source: Pediatrics, 1995, 95, 1, 74-81
  213. Antibodies against human putamen in children with Tourette syndrome
    Auteur: SINGER HS, GIULIANO JD, HANSEN BH et al
    Source: Neurology, 1998, 50, 1618-1624
  214. Volumetric MRI changes in basal ganglia of children with Gilles de la Tourette's syndrome
    Auteur: SINGER HS, REISS AL, BROWN JE et al
    Source: Neurology, 1993, 43, 950-956
  215. Desipramine treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, KERMAN K et al
    Source: J Am Acad Child Adolesc Psychiatry, 1993, 32, 2, 354-360
  216. Bupropion exacerbates tics in children with attention deficit hyperactivity disorder and Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, STEINGARD R et al
    Source: J Am Acad Child Adolesc Psychiatry, 1993, 32, 1, 211-214
  217. Tricyclic antidepressant treatment of children with ADHD and tics disorders
    Auteur: SPENCER T, BIEDERMAN J, WILENS T
    Source: J Am Acad Chid Adolesc Psychiatry, 1994, 33, 8, 1203-1204
  218. Nortriptyline treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, WILENS T
    Source: J am Acad Child Adolesc Psychiatry, 1993, 32, 1, 205-210
  219. rispÉridone for Tourette's syndrome
    Auteur: STAMENKOVIC M, ASCHAUER H, KASPER S
    Source: Lancet, 1994, 344, 1577-1578
  220. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders
    Auteur: STEINGARD R, BIEDERMAN J, SPENCER T, WILENS T, GONZALEZ A
    Source: J. AM; Acad. child Adolesc. Psychiatry, 32:2, March 1993
  221. Tourette's syndrome and obsessive compulsive disorder : clinical aspects
    Auteur: STEINGARD R, DILLON - STOUT D
    Source: Psychiatr Clin North Am, 1992, 15, 4, 849-860
  222. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD
    Auteur: STEINGARD RJ, GOLDBERG M, LEE D et al
    Source: J Am Acad Child Adolesc Psychiatry, 1994, 33, 3, 394-399
  223. The coexistence of tics and dystonia
    Auteur: STONE LA, JANKOVIC MDJ
    Source: Archives neurologiques, Vol 48, n°8, 862-865, 1991
  224. Gilles de la Tourette syndrome
    Auteur: SUCHOWERSHY O
    Source: Can J Neurosci, 1994, 21, 48-52
  225. Recent developments in neurobiology of OCD
    Auteur: SYMPOSIUM AMERICAN PSYCHIATRIC ASSOCIATION
    Source: A symposium sponsored by the american psychiatric association, Sunday, May 5, 1996
  226. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
    Auteur: SWEDO SE, LEONARD HL, MITTLEMAN BB et al
    Source: Am J Psychiatry, 1997, 154, 1, 110-112
  227. 137580 Gilles de la Tourette Syndrome
    Auteur: SYNDROME GILLES DE LA TOURETTE
    Source: Autosomal dominant catalog, 557-559
  228. Epidemiology of Tourette syndrome
    Auteur: TANNER CM, GOLDMAN SM
    Source: Neurol Clin North Am, 1997, 15, 2, 395-402
  229. Autisme : fifty years on from Kanner
    Auteur: TONGE BJ, DISSANAYAKE C, BRERETON AV
    Source: J. Paediatr Child Health, 30, 102-107, 1994
  230. Bulletin ÉtÉ 1999
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Tourette Syndrome Association
  231. The genetics of Tourette Syndrome
    Auteur: Tourette syndrome association
    Source: Internet
  232. Alternative / Complementary therapies for TS symptoms
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Internet
  233. MOZART (1756 - 1791)
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Internet
  234. SAMUEL JOHNSON (1709 - 1784)
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Internet
  235. Former major league Outfielder JIM EISENREICH
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Internet
  236. MAHMOUD ABDUL-RAUF, un basketteur du NBA dit Chris Jackso
    Auteur: TOURETTE SYNDROME ASSOCIATION
    Source: Internet
  237. Vocal tics in Gilles de la Tourette syndrome treated with notulinum toxin injections
    Auteur: TRIMBLE MR, WHURR R, BROOKES G et al
    Source: Mov Disord, 1998, 13, 3, 617-619
  238. Clonazepam, halopÉridol and Clonidine in tics disorders
    Auteur: TRUONG DD, BRESSMAN S, SHALE H et al
    Source: South Med J, 1988, 81, 9, 1103-1105
  239. The genetics of the Gilles de la Tourette syndrome : A review
    Auteur: Van de WETERING BJM, P HEUTINK
    Source: Department Psychiatry, university hospital Rotterdam, Nov 24, 1992
  240. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome : an open pilot dose titration study with rispÉridone
    Auteur: VAN DER LINDEN C, BRUGGEMAN R, VAN WOERKOM T
    Source: Mov Disord, 1994, 9, 6, 687-688
  241. The long term treatment of depressed patients with fluvoxamine (FL).
    Auteur: VARDY A, HOLLAND R
    Source: Proc 18th Coll int neuro-psychopharmacology cong.,Nice, 28 June -2 July 1992, Clin Neuropharmacol 1992, 15 (suppl 1, Pt B) : 333 B (Abs P-19-188)
  242. Periodic limb movements sleep are a frequent finding in patients with Gilles de la Tourette's Syndrome
    Auteur: VODERHOLZER U, MÜLLER N, HAAG C, RIEMAN D, STRAUBE A
    Source: J Neurol, 244 : 521-526, 1997
  243. Gilles de la Tourette's syndrome in a girl with fetal alcohol syndrome
    Auteur: VON GONTARD A, DEGET F
    Source: Journal of studies on alcohol, 57 (2), 219-220, mai 1996
  244. Family study and segregation analysis of Tourette syndrome. Evidence for a mixed model of inheritance.
    Auteur: WALKUP JT, LABUDA MC, SINGER HS
    Source: Am J Hum Genet, 1996, 59, 3, 684-693
  245. Tourette syndrome : associated symptoms and most disabling features
    Auteur: WAND RR, MATAZOW GS, SHADY GA et al
    Source: Neurosci Biobehav Rev, 1993, 17, 271-275
  246. D2-like dopamine receptor density in Tourette syndrome measured by PET
    Auteur: WONG DF, SINGER HS, BRANDT J, SHAYA E, CHEN C, BROWN J, KIMBALL AW, GJEDDE A, DANNALS RF, RAVERT HT, WILSON PD, WAGNER HN
    Source: Journal of nuclear medicine, 38(8), 1243-1247, 1997
  247. Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in tourette's syndrome : Preliminary report
    Auteur: YOUNG JG, COHEN DJ, HATTOX SE, KAVANAGH ME, ANDERSON GM, SHAYWITZ BA, MAAS JW
    Source: Life sciences, vol 29, pp1467-1475

Base bibliographique maintenue par AFSGT

remonter